Modification of the Activity of the Prefrontal Cortex by Virtual Distraction in the Lumbago

NCT ID: NCT04007302

Last Updated: 2019-07-08

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 15 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2018-09-09
• Study Completion Date: 2018-11-03

Brief Summary

The hypothesis of this work is that distraction is an effective way to modify the feeling and experience of chronic lumbar pain by modifying the functioning of the prefrontal cortex.

The main objective of this study is to show that during chronic low back pain generated during physical exercise, virtual reality distraction leads to the modification of the activity of the prefrontal cortex.

The secondary objectives are:

• Show a significant decrease in the average pain assessed with EVA during physical exercise with virtual reality distraction.
• Show an increase in the distance travelled with virtual reality distraction.
• Observe a decrease in perceived effort with virtual reality distraction.
• Quantify the adherence (presence) of subjects to the virtual environment

Detailed Description

A pre-test phase at D0 will be carried out with the objective of individually determining the exercise conditions (speed and slope) of walking that will generate lumbar pain. Patients who have not experienced lumbar pain during this phase will be excluded from the study. The patients included are then randomized according to the order of physical exercise situations.

For the tests, patients will be equipped with a miniaturized wireless (Octamon, Artinis) and multi-channel (8 optodes) NIRS device placed on the patient's frontal lobe according to EEG 10-20 positioning (fig. 2). They will then be placed on an inclined treadmill according to the angle that caused the pain during the pre-test.

During the test, subjects will walk to the voluntary stop and the different reasons for the stop (feeling of fatigue, pain, etc.) will be recorded by visual analogue scales and questionnaires. The duration of the exercise will be measured by a digital stopwatch connected to the treadmill. During physical exercise, the bilateral activity of the prefrontal cortex will be recorded continuously at a sampling frequency of 10 Hz.

For each test, subjects will be confronted with 2 situations, on D1 and D2. In a situation, walking will be done without distraction. In the other situation, the patient will be placed in front of a screen with virtual reality simulation while performing the walking exercise.

Conditions

Low Back Pain

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: CROSSOVER
• Primary Study Purpose: OTHER
• Blinding Strategy: NONE

Study Groups

walking with distraction

the patient walks in front of a screen with virtual reality simulation

Group Type: EXPERIMENTAL

measurement of bilateral activity of the prefrontal cortex by a NIRS system (near infrared spectroscopy)

Intervention Type: OTHER

measurement of the cerebral oxygenation response by the use of the Near Infrared Spectroscopy (NIRS) method

completion of questionnaires

Intervention Type: OTHER

igroup presence questionnaire (IPQ), Dallas Pain Questionnaire (DRAD), Fear-Avoidance Beliefs (FABQ) and Quebec Back Lumbago Scale

completion of questionnaires for pain

Intervention Type: OTHER

analogical visual and numerical scale and Borg scale

Walking without distraction

the patient walks on a treadmill without virtual reality simulation

Group Type: ACTIVE_COMPARATOR

measurement of bilateral activity of the prefrontal cortex by a NIRS system (near infrared spectroscopy)

Intervention Type: OTHER

measurement of the cerebral oxygenation response by the use of the Near Infrared Spectroscopy (NIRS) method

completion of questionnaires

Intervention Type: OTHER

igroup presence questionnaire (IPQ), Dallas Pain Questionnaire (DRAD), Fear-Avoidance Beliefs (FABQ) and Quebec Back Lumbago Scale

completion of questionnaires for pain

Intervention Type: OTHER

analogical visual and numerical scale and Borg scale

Interventions

measurement of bilateral activity of the prefrontal cortex by a NIRS system (near infrared spectroscopy)

measurement of the cerebral oxygenation response by the use of the Near Infrared Spectroscopy (NIRS) method

Intervention Type: OTHER

completion of questionnaires

igroup presence questionnaire (IPQ), Dallas Pain Questionnaire (DRAD), Fear-Avoidance Beliefs (FABQ) and Quebec Back Lumbago Scale

Intervention Type: OTHER

completion of questionnaires for pain

analogical visual and numerical scale and Borg scale

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• The patient must have given free and informed consent and signed the consent
• The patient must be a member or beneficiary of a health insurance plan
• The patient is available for a 3-day follow-up
• The patient is between 18 and 75 years old
• Disabling lumbar pain beyond three months

Exclusion Criteria

• Subject participates in another intervention study
• Subject is in an exclusion period determined by a previous study
• The subject is under the protection of justice, guardianship or curatorship
• Subject refuses to sign consent
• It is impossible to provide informed information about the subject
• The subject is unable to complete the study questionnaires
• The patient is pregnant, parturient, or breastfeeding
• The subject has a contraindication (or incompatible drug combination) for a treatment required for this study
• Recent involuntary weight loss
• Inflammatory schedule pain (predominantly nocturnal, requiring early morning rusting, improved by physical activity)
• Associated fever,
• Saddle anaesthesia
• Vesico-sphincterial disorders
• Typical root symptoms
• Systemic corticosteroid therapy
• History of cancer
• History of spinal trauma
• History of intravenous drug use
• Systemic corticosteroid therapy
• Surgical intervention of the spine or lower limbs
• Painful pathology of the lower limbs (coxarthrosis, gonarthrosis, vascular claudication or neurogenic when walking).

● Taking prescribed analgesic treatment after the inclusion procedure.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 75 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Centre Hospitalier Universitaire de Nīmes

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Anissa MEGZARI

Role: STUDY_DIRECTOR

Centre Hospitalier Universitaire de Nīmes

Locations

CHU de Nîmes

Nîmes, , France

Countries

France

Other Identifiers

2017-A02958-45

Identifier Type: OTHER

Identifier Source: secondary_id

LOCAL 2017/DMNG-01

Identifier Type: -

Identifier Source: org_study_id